ALLMedicine™ Glucagon Center
Research & Reviews 13,415 results
https://doi.org/10.1080/1061186X.2021.1894434
Journal of Drug Targeting; Poudwal S, Misra A et. al.
Feb 23rd, 2021 - A growing demand for insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RA) is observed, considering the progressive nature of diabetes and the potential therapeutic role of peptides in its treatment. However, the chronic parenteral admi...
https://doi.org/10.1073/pnas.2022142118
Proceedings of the National Academy of Sciences of the Un... Wang MY, Dean ED et. al.
Feb 23rd, 2021 - We evaluated the potential for a monoclonal antibody antagonist of the glucagon receptor (Ab-4) to maintain glucose homeostasis in type 1 diabetic rodents. We noted durable and sustained improvements in glycemia which persist long after treatment ...
https://doi.org/10.1038/s41380-021-01043-y 10.1001/jamapsychiatry.2015.0584 10.1016/S0006-3223(97)00426-5 10.4172/2155-6105.1000281 10.1111/j.1471-4159.1991.tb08205.x 10.1046/j.1360-0443.2002.00158.x 10.1111/j.1476-5381.1993.tb13569.x 10.1300/J069v16n03_08 10.1152/physrev.00034.2006 10.1016/S0306-4522(03)00383-X 10.1523/JNEUROSCI.17-02-00851.1997 10.1016/j.physbeh.2019.112771 10.1016/j.celrep.2015.06.062 10.1038/npp.2015.362 10.1371/journal.pone.0077284 10.1016/j.psyneuen.2012.11.009 10.1111/adb.12583 10.1016/j.neuropharm.2018.01.013 10.1016/j.physbeh.2019.03.026 10.1016/j.pharmthera.2014.11.011 10.1073/pnas.0507332102 10.1038/sj.npp.1301666 10.4155/fmc.11.181 10.1155/2011/601047 10.1016/j.stem.2017.06.016 10.1038/s41551-018-0293-z 10.1016/0091-3057(95)00098-H 10.1016/j.legalmed.2012.04.008 10.1124/jpet.102.041350 10.1002/syn.10226 10.1074/jbc.M115.671743 10.1126/scitranslmed.3009540 10.1016/j.psyneuen.2019.02.006 10.1385/JMN:18:1-2:07 10.1517/14740338.7.5.571 10.1523/JNEUROSCI.4520-07.2008 10.1007/s00213-018-5024-3 10.1016/0305-4179(94)90017-5 10.1038/nature24487 10.1210/en.2009-0915 10.1523/JNEUROSCI.3464-14.2015 10.1016/j.jchemneu.2008.07.009 10.1038/nn.4540 10.1111/jnc.14008
Molecular Psychiatry; Kong Q, Li Y et. al.
Feb 23rd, 2021 - Alcohol use disorder (AUD) is one of the foremost public health problems. Alcohol is also frequently co-abused with cocaine. There is a huge unmet need for the treatment of AUD and/or cocaine co-abuse. We recently demonstrated that skin grafts gen...
https://doi.org/10.1007/s11695-021-05264-6 10.1210/endo.141.12.7806 10.1152/ajpendo.00529.2004 10.1016/B978-0-12-800101-1.00002-8 10.4161/isl.20500 10.1016/j.cmet.2014.03.010 10.1016/j.cmet.2013.12.002 10.1172/JCI88015 10.1111/j.1463-1326.2011.01442.x 10.1016/j.cmet.2009.02.007 10.1016/j.cmet.2017.01.009 10.1038/s41598-019-51347-x 10.1016/j.metabol.2019.153963 10.2337/db11-1605 10.12659/MSM.902230 10.1056/NEJMoa043690 10.1016/j.isci.2019.100798 10.1038/387406a0 10.1074/jbc.274.7.4124
Obesity Surgery; Bancalero-delosReyes J, Camacho-Ramírez A et. al.
Feb 23rd, 2021 - Many studies about bariatric surgery have analyzed the effect of sleeve gastrectomy (SG) on glucose improvement, beta-cell mass, and islet size modification. The effects of SG on the other endocrine cells of the pancreas, such as the alpha-cell po...
https://doi.org/10.1177/2047487320918722
European Journal of Preventive Cardiology; Chan JSK
Feb 21st, 2021 - The results are in: Cardiovascular benefits of glucagon-like peptide-1 receptor agonists - a trial sequential analysis.|2021|Chan JSK,|
Guidelines 15 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971782
Diabetes Care; Buse JB, Wexler DJ et. al.
Dec 20th, 2019 - The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials...
https://www.novonordisk-us.com/media/news-releases.html?122973
Sep 19th, 2019 - Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with diet and exercise may improve blood sugar (glucose).1 Rybelsus...
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30311-0/fulltext
The Lancet Diabetes & Endocrinology; Lingvay,I.,et al
Sep 16th, 2019 - Existing guidelines for management of type 2 diabetes recommend a patient-centred approach to guide the choice of pharmacological agents. Although glucagon-like peptide-1 (GLP-1) receptor agonists and sodium–glucose cotransporter-2 (SGLT2) inhibit...
https://xerispharma.gcs-web.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-us-fda-approval-gvoketm-glucagon
Sep 9th, 2019 - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received reg...
https://www.aafp.org/afp/2019/0801/p134.html
American Family Physician; Moin,T.
Aug 1st, 2019 - A surge in the prevalence of prediabetes1 highlights the importance of improving prediabetes awareness and engaging in strategies to lower the risk of type 2 diabetes mellitus. Based on evidence from randomized controlled trials and observational ...
Drugs 91 results see all →
Clinicaltrials.gov 13,831 results
https://doi.org/10.1080/1061186X.2021.1894434
Journal of Drug Targeting; Poudwal S, Misra A et. al.
Feb 23rd, 2021 - A growing demand for insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RA) is observed, considering the progressive nature of diabetes and the potential therapeutic role of peptides in its treatment. However, the chronic parenteral admi...
https://doi.org/10.1073/pnas.2022142118
Proceedings of the National Academy of Sciences of the Un... Wang MY, Dean ED et. al.
Feb 23rd, 2021 - We evaluated the potential for a monoclonal antibody antagonist of the glucagon receptor (Ab-4) to maintain glucose homeostasis in type 1 diabetic rodents. We noted durable and sustained improvements in glycemia which persist long after treatment ...
https://doi.org/10.1038/s41380-021-01043-y 10.1001/jamapsychiatry.2015.0584 10.1016/S0006-3223(97)00426-5 10.4172/2155-6105.1000281 10.1111/j.1471-4159.1991.tb08205.x 10.1046/j.1360-0443.2002.00158.x 10.1111/j.1476-5381.1993.tb13569.x 10.1300/J069v16n03_08 10.1152/physrev.00034.2006 10.1016/S0306-4522(03)00383-X 10.1523/JNEUROSCI.17-02-00851.1997 10.1016/j.physbeh.2019.112771 10.1016/j.celrep.2015.06.062 10.1038/npp.2015.362 10.1371/journal.pone.0077284 10.1016/j.psyneuen.2012.11.009 10.1111/adb.12583 10.1016/j.neuropharm.2018.01.013 10.1016/j.physbeh.2019.03.026 10.1016/j.pharmthera.2014.11.011 10.1073/pnas.0507332102 10.1038/sj.npp.1301666 10.4155/fmc.11.181 10.1155/2011/601047 10.1016/j.stem.2017.06.016 10.1038/s41551-018-0293-z 10.1016/0091-3057(95)00098-H 10.1016/j.legalmed.2012.04.008 10.1124/jpet.102.041350 10.1002/syn.10226 10.1074/jbc.M115.671743 10.1126/scitranslmed.3009540 10.1016/j.psyneuen.2019.02.006 10.1385/JMN:18:1-2:07 10.1517/14740338.7.5.571 10.1523/JNEUROSCI.4520-07.2008 10.1007/s00213-018-5024-3 10.1016/0305-4179(94)90017-5 10.1038/nature24487 10.1210/en.2009-0915 10.1523/JNEUROSCI.3464-14.2015 10.1016/j.jchemneu.2008.07.009 10.1038/nn.4540 10.1111/jnc.14008
Molecular Psychiatry; Kong Q, Li Y et. al.
Feb 23rd, 2021 - Alcohol use disorder (AUD) is one of the foremost public health problems. Alcohol is also frequently co-abused with cocaine. There is a huge unmet need for the treatment of AUD and/or cocaine co-abuse. We recently demonstrated that skin grafts gen...
https://doi.org/10.1007/s11695-021-05264-6 10.1210/endo.141.12.7806 10.1152/ajpendo.00529.2004 10.1016/B978-0-12-800101-1.00002-8 10.4161/isl.20500 10.1016/j.cmet.2014.03.010 10.1016/j.cmet.2013.12.002 10.1172/JCI88015 10.1111/j.1463-1326.2011.01442.x 10.1016/j.cmet.2009.02.007 10.1016/j.cmet.2017.01.009 10.1038/s41598-019-51347-x 10.1016/j.metabol.2019.153963 10.2337/db11-1605 10.12659/MSM.902230 10.1056/NEJMoa043690 10.1016/j.isci.2019.100798 10.1038/387406a0 10.1074/jbc.274.7.4124
Obesity Surgery; Bancalero-delosReyes J, Camacho-Ramírez A et. al.
Feb 23rd, 2021 - Many studies about bariatric surgery have analyzed the effect of sleeve gastrectomy (SG) on glucose improvement, beta-cell mass, and islet size modification. The effects of SG on the other endocrine cells of the pancreas, such as the alpha-cell po...
https://www.medscape.com/viewarticle/946392
Feb 23rd, 2021 - Results showing once-weekly subcutaneous semaglutide, as an adjunct to intensive behavioral therapy and an initial low calorie diet, induced weight loss that was 10.3% greater compared with placebo over 68 weeks in people with obesity or overweigh...
News 477 results
https://www.medscape.com/viewarticle/946392
Feb 23rd, 2021 - Results showing once-weekly subcutaneous semaglutide, as an adjunct to intensive behavioral therapy and an initial low calorie diet, induced weight loss that was 10.3% greater compared with placebo over 68 weeks in people with obesity or overweigh...
https://www.medscape.com/viewarticle/945630
Feb 9th, 2021 - The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named, some say. "In sum, we have a long way to go to control the obesity epidemic. "Pressing Ne...
https://www.medscape.com/viewarticle/945430
Feb 7th, 2021 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes appear to confer greater cardiovascular benefit than glucagon-like peptide-1 (GLP-1) receptor agonists among older adults with a history of cardiovascular disease (CVD), ac...
https://www.medscape.com/viewarticle/943944
Jan 12th, 2021 - Takeaway Glucagon-like peptide-1 (GLP-1) agonists are efficacious in treating children with obesity and type 2 diabetes mellitus (T2DM).
https://www.medscape.com/viewarticle/943385
Dec 29th, 2020 - The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA determined that Amphastar Pharmaceuticals' Glucagon ...
